SCPH Market Cap History



Below is a table of the SCPH market cap history going back to 11/17/2017:

Date SCPH Market Cap
11/17/2017248.30M
3/16/2018260.41M
5/4/2018221.02M
8/13/201884.49M
11/13/201894.70M
3/19/201959.46M
5/7/201965.77M
8/6/201995.69M
8/5/2019261.17M
11/11/2019103.23M
3/23/2020117.50M
11/12/2020247.25M
3/22/2021193.68M
5/12/2021158.11M
8/10/2021151.55M
11/8/2021173.43M
3/21/2022141.24M
5/31/2022131.38M
8/8/2022146.60M
11/8/2022154.45M
3/21/2023247.88M
5/9/2023403.12M
8/9/2023281.48M
11/7/2023183.96M
3/12/2024193.25M

Also see: SCPH Shares Outstanding History
and SCPH YTD Return
SCPH Historical Market Cap:
-3.89% CAGR
SCPH Historical Market Cap: +-3.89% CAGR

Mouse over chart for data details
11/17/2017 ...3/12/2024
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that have the potential to improve the delivery of infused therapies and develop patient care. Co.'s product, FUROSCIX®, consists of its formulation of furosemide delivered via West Pharmaceutical Services, Inc.'s on-body infusor, and is used for the treatment of congestion due to fluid overload in adults with New York Heart Association Class II/III chronic heart failure. FUROSCIX is a subcutaneous loop diuretic that delivers intravenous equivalent diuresis at home. We show 25 historical shares outstanding datapoints in our SCPH shares outstanding history coverage, used to compute SCPH market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SCPH market cap history over the course of time is important for investors interested in comparing SCPH's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SCPH versus a peer is one thing; comparing SCPH market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SCPH can fluctuate over the course of history. With this page we aim to empower investors researching SCPH by allowing them to research the SCPH market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree SCPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
scPharmaceuticals (SCPH) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

SCPS Market Cap History
SCTL Market Cap History
SCYX Market Cap History
SDC Market Cap History
SDGR Market Cap History
SEEL Market Cap History
SEER Market Cap History
SELB Market Cap History
SEM Market Cap History
SERA Market Cap History
More Healthcare companies »

 

SCPH Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.